Health
Drugmakers Will Ask Trump to Pause Price Negotiations
- Lilly is pushing Trump to cover weight-loss drugs for elderly
- Biden IRA drug target list expected before inauguration
The outgoing administration is planning to release a list of the next set of drugs eligible for negotiation before leaving office.
Photographer: Daniel Acker/BloombergThis article is for subscribers only.
Eli Lilly & Co. said it and other drugmakers will ask the Trump administration to pause drug-price negotiations, even as Biden-appointed officials prepare a new list of medicines that should be targeted.
“They need to fix it” before negotiating down the price of more drugs, Lilly Chief Executive Officer Dave Ricks said on the sidelines of the JPMorgan Healthcare Conference in San Francisco, referring to the Inflation Reduction Act.